- Immune profiling|based targeting of pathogenic T cells with ...🔍
- Immune pro ling|based targeting of pathogenic T cells with ...🔍
- Immune profiling|based targeting of pathogenic T cells with...🔍
- Immune Profiling|Based Targeting of Pathogenic T Cells with ...🔍
- Katalin Susztak on X🔍
- In|depth immune profiling reveals advanced B| and T|cell ...🔍
- Targeting pathogenic CD8+ tissue|resident T cells with chimeric ...🔍
- Immune|based🔍
Immune profiling|based targeting of pathogenic T cells with ...
Immune profiling-based targeting of pathogenic T cells with ... - Nature
We treat four ANCA-GN patients with ustekinumab, which specifically targets Th1 and Th17 cells, as add-on therapy.
Immune profiling-based targeting of pathogenic T cells with ...
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis. Nat Commun. 2024 Sep 19;15(1):8220. doi: ...
Immune pro ling-based targeting of pathogenic T cells with ...
Our ndings suggest that immune-pro ling-based targeting of pathogenic T cells in ANCA-GN patients with ustekinumab is a promising approach ...
(PDF) Immune profiling-based targeting of pathogenic T cells with ...
Our findings thus suggest that targeting of pathogenic T cells in ANCA-GN patients with ustekinumab might represent a potential approach and ...
Immune profiling-based targeting of pathogenic T cells with ...
It is suggested that targeting of pathogenic T cells in ANCA-GN patients with ustekinumab might represent a potential approach and warrants further ...
Immune profiling-based targeting of pathogenic T cells with... - CiteAb
6 reagents referenced in Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis.
Immune Profiling-Based Targeting of Pathogenic T Cells with ...
Immune Profiling-Based Targeting of Pathogenic T Cells with Ustekinumab in ANCA-Associated Glomerulonephritis: SA-PO756 · October 2024 · Journal ...
Katalin Susztak on X: "Immune profiling-based targeting of ...
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis | @NatureComms ...
Immune profiling-based targeting of pathogenic T cells with ... - CoLab
AbstractAntineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a life-threatening autoimmune disease that often results in kidney failure ...
In-depth immune profiling reveals advanced B- and T-cell ...
Unbiased clustering of T cell mass cytometry data correlated with CVID-related immune dysregulation and plasma protein profiles. Expanded CXCR3+ T-bet- ...
Targeting pathogenic CD8+ tissue-resident T cells with chimeric ...
Liver CD8+ Trm cells also upregulate the expression of several immune checkpoint molecules, including PD-1. We describe the development of a ...
Immune-based, multifaceted inactivation of pathogenic T ...
Immunotherapeutic treatment of autoimmune diseases should aim to inactivate autoaggressive memory T-cells and restore immune tolerance.
Hitting the target: how T cells detect and eliminate tumors - PMC
... profiling have produced insights into the specific targets of anti-tumor T cells ... immunity, which has primarily evolved in response to foreign pathogens.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in ...
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, ...
Immune profiling involves the analysis of T- and B-cell receptors (TCRs/BCRs), which allow cells to bind specific antigens, proliferate, and then rapidly ...
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
The CAR T-cell therapies approved by FDA to date target one of two antigens on B cells, CD19 or BCMA. Making a CAR T Cell. A growing number of ...
Single-cell immune profiling reveals functional diversity of T cells in ...
Granzyme K–expressing CD8 T cells were preferentially enriched and clonally expanded in pleural fluid from TPE, suggesting that they are ...
Review article Role of T cells in cancer immunotherapy
This review addresses all the strategies targeting tumor pathogenesis, including metabolic pathways, to evaluate the clinical significance of current and ...
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells ...
The CD4+ T-cell compartment showed an increase of pathogenic T-helper 17.1 cells, characterized by high co-expression of TBX21 (encoding T-bet) and RORC (ROR-γ) ...
Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical ...
T cells carrying the γδ T cell receptor (TCR) are important effector cells that may play a role in the anti-tumor immune response. γδ Cells are not a ...